Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 77.17% is 34% above its 5-year average of 57.40%, near the high end of its 5-year range (33.55%–79.78%).
As of the fiscal period ended Tuesday, June 30, 2026. 18.54% above its 12-month average of 65.11%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 77.17%.
DEBT TO ASSETS RATIO
77.17%
DEBT TO ASSETS RATIO AVG TTM
65.11%
DEBT TO ASSETS RATIO AVG 3Y
64.24%
DEBT TO ASSETS RATIO AVG 5Y
57.40%
DEBT TO ASSETS RATIO AVG 10Y
40.24%
DEBT TO ASSETS RATIO AVG 15Y
35.59%
DEBT TO ASSETS RATIO AVG 20Y
37.06%
CURRENT VS TTM AVG
+18.54%
CURRENT VS 3Y AVG
+20.14%
CURRENT VS 5Y AVG
+34.44%
CURRENT VS 10Y AVG
+91.78%
CURRENT VS 15Y AVG
+116.84%
CURRENT VS 20Y AVG
+108.24%
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+85649.85%
vs the sector median at left
Travere Therapeutics, Inc.
Market Cap
$5.21B
Debt to Assets Ratio
77.17%
TTM Avg
65.11%
3Y Avg
64.24%
5Y Avg
57.40%
Market Cap
$5.20B
Debt to Assets Ratio
0.69%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.21B
Debt to Assets Ratio
0.30%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.19B
Debt to Assets Ratio
0.29%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.32B
Debt to Assets Ratio
0.21%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.09B
Debt to Assets Ratio
0.39%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.07B
Debt to Assets Ratio
0.29%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.06B
Debt to Assets Ratio
0.25%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | $5.21B | 77.17% | 65.11% | 64.24% | 57.40% |
| Sotera Health Company (SHC)vs › | $5.20B | 0.69% | N/A | N/A | N/A |
| CRISPR Therapeutics AG (CRSP)vs › | $5.21B | 0.30% | N/A | N/A | N/A |
| Doximity, Inc. (DOCS)vs › | $5.20B | 0.01% | N/A | N/A | N/A |
| Cogent Biosciences, Inc. (COGT)vs › | $5.19B | 0.29% | N/A | N/A | N/A |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.32B | 0.21% | N/A | N/A | N/A |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.09B | 0.39% | N/A | N/A | N/A |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.07B | 0.29% | N/A | N/A | N/A |
| Waystar Holding Corp. (WAY)vs › | $5.06B | 0.25% | N/A | N/A | N/A |
| Erasca, Inc. (ERAS)vs › | $4.96B | 0.10% | N/A | N/A | N/A |
Debt/Assets
77.2%
Debt/Equity
25.16
Current Ratio
4.05
Interest Coverage
-5.8x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 77.17% |
| 2026-03-31 | 59.02% |
| 2025-12-31 | 56.16% |
| 2025-09-30 | 61.23% |
| 2025-06-30 | 71.96% |
| 2025-03-31 | 72.97% |
| 2024-12-31 | 67.59% |
| 2024-09-30 | 79.78% |
| 2024-06-30 | 73.16% |
| 2024-03-31 | 60.89% |
| 2023-12-31 | 51.31% |
| 2023-09-30 | 48.69% |
| 2023-06-30 | 55.15% |
| 2023-03-31 | 50.34% |
| 2022-12-31 | 60.59% |
| 2022-09-30 | 56.13% |
| 2022-06-30 | 52.36% |
| 2022-03-31 | 49.35% |
| 2021-12-31 | 33.73% |
| 2021-09-30 | 33.55% |
| 2021-06-30 | 34.33% |
| 2021-03-31 | 32.77% |
| 2020-12-31 | 40.17% |
| 2020-09-30 | 34.87% |
| 2020-06-30 | 30.94% |
| 2020-03-31 | 36.19% |
| 2019-12-31 | 33.87% |
| 2019-09-30 | 32.97% |
| 2019-06-30 | 30.87% |
| 2019-03-31 | 32.95% |
| 2018-12-31 | 30.68% |
| 2018-09-30 | 30.04% |
| 2018-06-30 | 9.24% |
| 2018-03-31 | 9.03% |
| 2017-12-31 | 8.66% |
| 2017-09-30 | 8.63% |
| 2017-06-30 | 8.82% |
| 2017-03-31 | 8.74% |
| 2016-12-31 | 8.46% |
| 2016-09-30 | 8.31% |
| 2016-06-30 | 8.26% |
| 2016-03-31 | 8.66% |
| 2015-12-31 | 8.57% |
| 2015-09-30 | 8.55% |
| 2015-06-30 | 19.93% |
| 2015-03-31 | 20.25% |
| 2014-12-31 | 61.84% |
| 2014-09-30 | 57.08% |
| 2014-06-30 | 53.24% |
| 2014-03-31 | 33.26% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.05% |
| 2013-06-30 | 0.37% |
| 2013-03-31 | 0.20% |
| 2012-12-31 | 641.03% |
| 2012-08-31 | 641.03% |
| 2012-05-31 | 641.03% |
| 2012-02-29 | 639.55% |
| 2011-11-30 | 642.51% |
| 2011-08-31 | 639.55% |
| 2011-05-31 | 635.49% |
| 2011-02-28 | 631.63% |
| 2010-08-31 | 495.12% |
| 2010-05-31 | 427.59% |
| 2009-11-30 | 290.29% |
| 2009-08-31 | 222.44% |
| 2009-05-31 | 153.47% |
| 2008-05-31 | 0.00% |
